[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Breast Implants Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

December 2017 | 194 pages | ID: B128E4926F3EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The breast implants treatment market is increasing at a significant CAGR due to increase in the female population. Rising prevalence of breast cancer cases, growing demand for cosmetic surgeries, and women with a high preference for improving aesthetic appeal might fuel the growth of the breast implants market over the forecast period. Moreover, an increase in the awareness about reconstructive breast surgeries, favorable demographics across the globe, and an increase in aging population are the key factors propelling the global breast implants market growth. However, increased risk of developing serious complications including deflation, capsular contracture, infection, and breast and nipple sensitivity, and high costs of the implant procedures are the major factors hampering the growth of the global breast implants market over the forecast period.

Breast Implants Market

Breast implants are the medical devices, used in the post-mastectomy to improve the aesthetic appeal. Breast implants are made up of a silicone outer shell and a filler such as silicone gel or saline. Breast implantation can be done by reconstructive plastic surgery or surgical practice. In reconstructive surgery process, the implants are inserted to correct deformities and congenital defects of the chest wall and also used to restore a natural appearance of a breast mound of post-mastectomy breast reconstruction patients. In surgical practice, tissue expander devices are used as temporary breast prosthesis to establish and form an implant pocket for the administration of permanent breast implants. In males, pectoral implants are used as a prosthesis for the aesthetic repair and reconstruction of the chest wall to correct the deformities and defects in the chest.

The breast implants market is segmented on the basis of product type, application type, and end user

Based on product type, the breast implants market has been segmented into the following:

Silicone breast implants
Structured saline breast implants
Saline breast implants
Gummy bear breast implants
Round breast implants
Smooth breast implants
Textured breast implants

Based on treatment type, the breast implants market has been segmented into the following:

Reconstructive surgery
Cosmetic surgery

Based on the end user, the breast implants market has been segmented into the following:

Hospitals
Cosmetology clinics
Ambulatory surgical centres

Global breast implants market is in growing stage with the innovation of novel implants into the breast implants market. Increase in the prevalence of breast cancer cases, (according to World Health Organization every year around 200,000 new cases in women), growing preference for enhancing physical appearance might fuel the breast implants market. According to American Society of Plastic Surgeons (ASPS), breast augmentation surgeries were increased about 31% from 2000 to 2015. Launching of new products, innovation of less invasive surgical procedures, and product approvals from various regulatory bodies such as U.S. Food and Drug Administration might boost the breast implants market over the forecast period. For instance, in February 2013, FDA approved a silicone gel-filled breast implant manufactured by Allergan Plc, which uses more cohesive silicone gel, compared with previously approved breast implants. Similarly, In June 2013, the U.S. FDA has approved a silicone gel-filled breast implant which uses a more cohesive silicone gel manufactured by Mentor’s PMA, compared with their previously approved breast implants. Moreover, acquisitions and mergers, collaborations, and key licensing agreements also bolster the breast implants market growth. For instance, in December 2008, Johnson & Johnson has acquired breast-implant maker Mentor Corporation for the manufacturing of breast implants. In March 2015, Actavis plc has acquired of Allergan, Inc. to manufacture breast implants.

Geographically, the breast implants market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America dominates the Breast Implants market due to increase in the prevalence of breast cancer disease, rise in the female geriatric population and government welfare initiatives. Increase in the healthcare infrastructure, favourable reimbursement policies, and increase in the women with a high preference for cosmetic surgery (according to the American Society of Plastic Surgeons (ASPS), 279,143 number of procedures related to breast augmentation had taken place in the U.S. in 2015). Europe holds a significant share in breast implants market owing to rise in the prevalence and incidence of breast cancer cases (According to World Cancer Research Fund International, nearly 1.7 million new breast cancer cases were diagnosed in 2012. In the UK itself, 53,696 new cases were diagnosed in 2013). Moreover, change in the lifestyle, increase in the number of cosmetology clinics, and huge awareness levels regarding cosmetic surgeries also boost the breast implants market. Asia-Pacific is anticipated to be the fastest growing market over the forecast period owing to increasing disposable income, low-cost treatment in the field of medical tourism might propel the breast implants market in this region over the forecasting period.

Some of the players in the breast implants market are Allergan (U.S.), GC. Aesthetics (Ireland), Groupe Seb (France), Johnson & Johnson Services Inc.,(U.S.), Sientra, Inc. (U.S.), Polytech Health & Aesthetics GmbH (Germany), Establishment Labs S.A. (Costa Rica), Shanghai Kangning Medical Supplies Ltd. (China), Guangzhou Wanhe Plastic Materials Co., Ltd. (China), Laboratoires Arion (France), and Hansbiomed Co. Ltd (Korea).

In January 2016, Allergan plc received approval from the U.S. Food and Drug Administration (FDA) to market Natrelle Inspira Soft touch breast implants

In June 2016, Establishment labs received approval from the Korean Food & Drug Administration (KFDA) for Motiva Implants
1. EXECUTIVE SUMMARY

2. GLOBAL BREAST IMPLANTS MARKET INTRODUCTION

2.1. Global Breast Implants Market – Taxonomy
2.2. Global Breast Implants Market –Definitions
  2.2.1. Product Type
  2.2.2. Treatment Type
  2.2.3. End User

3. GLOBAL BREAST IMPLANTS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Breast Implants Market Dynamic Factors - Impact Analysis
3.6. Global Breast Implants Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe
3.7. Global Breast Implants Market –Trends

4. GLOBAL BREAST IMPLANTS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL BREAST IMPLANTS MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. Silicone breast implants
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Structured saline breast implants
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Saline breast implants
  5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Gummy bear breast implants
  5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Round breast implants
  5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Smooth breast implants
  5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Textured breast implants
  5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis

6. GLOBAL BREAST IMPLANTS MARKET FORECAST, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023

6.1. Reconstructive surgery
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Cosmetic surgery
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis

7. GLOBAL BREAST IMPLANTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Cosmetology clinics
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centres
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL BREAST IMPLANTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. North America
  8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Region, 2017 – 2023

9. NORTH AMERICA BREAST IMPLANTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Silicone breast implants
  9.1.2. Structured saline breast implants
  9.1.3. Saline breast implants
  9.1.4. Gummy bear breast implants
  9.1.5. Round breast implants
  9.1.6. Smooth breast implants
  9.1.7. Textured breast implants
9.2. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Reconstructive surgery
  9.2.2. Cosmetic surgery
9.3. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Hospitals
  9.3.2. Cosmetology clinics
  9.3.3. Ambulatory surgical centres
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Country, 2017 – 2023
9.6. North America Breast Implants Market Dynamics – Trends

10. EUROPE BREAST IMPLANTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Silicone breast implants
  10.1.2. Structured saline breast implants
  10.1.3. Saline breast implants
  10.1.4. Gummy bear breast implants
  10.1.5. Round breast implants
  10.1.6. Smooth breast implants
  10.1.7. Textured breast implants
10.2. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Reconstructive surgery
  10.2.2. Cosmetic surgery
10.3. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Hospitals
  10.3.2. Cosmetology clinics
  10.3.3. Ambulatory surgical centres
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Germany
  10.4.2. UK
  10.4.3. France
  10.4.4. Spain
  10.4.5. Italy
  10.4.6. Russia
  10.4.7. Poland
  10.4.8. Rest of Europe
10.5. Europe Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Country, 2017 – 2023
10.6. Europe Breast Implants Market Dynamics – Trends

11. ASIA-PACIFIC BREAST IMPLANTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Silicone breast implants
  11.1.2. Structured saline breast implants
  11.1.3. Saline breast implants
  11.1.4. Gummy bear breast implants
  11.1.5. Round breast implants
  11.1.6. Smooth breast implants
  11.1.7. Textured breast implants
11.2. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Reconstructive surgery
  11.2.2. Cosmetic surgery
11.3. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Hospitals
  11.3.2. Cosmetology clinics
  11.3.3. Ambulatory surgical centres
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Country, 2017 – 2023
11.6. Asia-Pacific Breast Implants Market Dynamics – Trends

12. LATIN AMERICA BREAST IMPLANTS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Silicone breast implants
  12.1.2. Structured saline breast implants
  12.1.3. Saline breast implants
  12.1.4. Gummy bear breast implants
  12.1.5. Round breast implants
  12.1.6. Smooth breast implants
  12.1.7. Textured breast implants
12.2. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Reconstructive surgery
  12.2.2. Cosmetic surgery
12.3. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Hospitals
  12.3.2. Cosmetology clinics
  12.3.3. Ambulatory surgical centres
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
12.5. Latin America Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Country, 2017 – 2023
12.6. Latin America Breast Implants Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA BREAST IMPLANTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

13.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Silicone breast implants
  13.1.2. Structured saline breast implants
  13.1.3. Saline breast implants
  13.1.4. Gummy bear breast implants
  13.1.5. Round breast implants
  13.1.6. Smooth breast implants
  13.1.7. Textured breast implants
13.2. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. Reconstructive surgery
  13.2.2. Cosmetic surgery
13.3. End User Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Hospitals
  13.3.2. Cosmetology clinics
  13.3.3. Ambulatory surgical centres
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  13.4.1. Gulf Cooperation Council (GCC) Countries
  13.4.2. Israel
  13.4.3. South Africa
  13.4.4. Rest of MEA
13.5. MEA Breast Implants Market - Opportunity Analysis Index, By Product Type, By Treatment Type, By Distribution Channel and Country, 2017 – 2023
13.6. MEA Breast Implants Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Allergan (U.S.)
  14.2.2. GC. Aesthetics (Ireland)
  14.2.3. Groupe Seb (France)
  14.2.4. Johnson & Johnson Services Inc.,(U.S.)
  14.2.5. Sientra, Inc. (U.S.)
  14.2.6. Polytech Health & Aesthetics GmbH (Germany)
  14.2.7. Establishment Labs S.A. (Costa Rica)
  14.2.8. Shanghai Kangning Medical Supplies Ltd. (China)
  14.2.9. Guangzhou Wanhe Plastic Materials Co., Ltd. (China)
  14.2.10. Laboratoires Arion (France)
  14.2.11. Hansbiomed Co. Ltd (Korea)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS




More Publications